Sector ratings CureVac N.V.

Equities

CVAC

NL0015436031

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-17 pm EDT			5-day change	1st Jan Change
5.500 ^USD	-0.36%		+22.77%	+61.29%

Jun. 16	CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances	RE
Jun. 13	Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Consensus (Composite)	Financial estimates revisions (Composite)	Visibility (Composite)	Investor (Composite)	ESG MSCI	Capi.($)
	CUREVAC N.V.	-	-				-	BBB	1.24B
	LONZA GROUP AG							AAA	49.38B
	IQVIA HOLDINGS INC.							AA	27.55B
	CELLTRION, INC.							BBB	26.36B
	EUROFINS SCIENTIFIC SE							AA	12.75B
	ICON PUBLIC LIMITED COMPANY							AA	11.68B
	QIAGEN N.V.							AAA	10.28B
	MEDPACE HOLDINGS, INC.							BBB	8.65B
	BIO-TECHNE CORPORATION							A	8.09B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.							A	7.42B
	HANGZHOU TIGERMED CONSULTING CO., LTD							AA	5.92B
	PHARMARON BEIJING CO., LTD.							AA	5.71B
	TELIX PHARMACEUTICALS LIMITED							A	5.66B
	Average							AA	13.9B
	Weighted average by Cap.							AA

Other Biotechnology & Medical Research